The results are in and show that about half of our respondents report prescribing a saline solution when they prescribe a hydrogen peroxide care system to their contact lens patients. I have found that this can be a great help to the patient; some prefer to give their lenses a rinse with saline following removal from the lens case (that contains neutralized hydrogen peroxide). Likewise, keeping saline on hand can also be helpful to patients who need to remove a contact lens for some reason midday, or to patients who mishandle their lens upon application and need to start the process over. As such, I generally advise that our hydrogen peroxide users keep saline on hand as you never know when they might need it.
Jason J. Nichols, OD, MPH, PhD
Johnson & Johnson Vision Acquires Sightbox
Johnson & Johnson Vision (J&J Vision) has acquired Sightbox, Inc., an online, membership-based subscription service for contact lens wearers in the United States. Sightbox helps patients connect with eyecare professionals and addresses a growing consumer preference for more convenient access to eye health services and products, according to J&J Vision.
Sightbox services include scheduling a comprehensive, annual eye exam and contact lens evaluation as well as an annual supply of contact lenses for members. The company’s growth has been primarily fueled by private pay patients who do not have vision insurance. This model encourages people who may not otherwise do so to visit an eyecare professional and enter the category.
While Sightbox will become part of J&J Vision, it will operate as a separate business, leveraging its own unique business model. Sightbox will continue to provide contact lenses from all major manufacturers. The acquisition is complementary to J&J Vision’s strategy to become a broad-based, global leader in eye health, and it further enhances the company’s leading eye health portfolio, according to J&J Vision.
J&J Vision acquired Sightbox, Inc. through its Vision Care operating company, Johnson & Johnson Vision Care, Inc. Sightbox sales will be reported through the Medical Devices segment, under Vision Care. Financial terms of the transaction have not been disclosed.
SpecialEyes Appoints Korinne Andrew as Lead Consultant
SpecialEyes, LLC has promoted Korinne Andrew to lead consultant. In her newly expanded position, she will oversee toric and multifocal toric contact lens consultations with eyecare practitioners nationwide.
Ms. Andrew, who holds National Contact Lens Examiners (NCLE) certification, joined SpecialEyes in 2012 as a product specialist and will retain that role in addition to her new responsibilities. As product specialist, she analyzes contact lens data and outcomes and uses that information to develop product and consultative improvements.
Johnson & Johnson Vision Launches Acuvue Vita for Astigmatism
Johnson & Johnson Vision (J&J Vision) has announced the U.S. launch of Acuvue Vita Brand Contact Lenses for Astigmatism, a daily wear, monthly replacement contact lens.
Acuvue Vita for Astigmatism combines two technologies: 1) HydraMax Technology, which is a non-coated silicone hydrogel formulation balanced to help maximize and maintain hydration throughout the lens for reliable, exceptional comfort all month long, according to the company; and 2) Blink-Stabilized Design, which the company says works naturally with the eyelids, helping to keep the lens in the correct position.
Acuvue Vita for Astigmatism provides Class I UV protection, blocking approximately 93% of UVA and 99% of UVB rays. J&J Vision will launch Acuvue Vita for Astigmatism through its operating company, Johnson & Johnson Vision Care, Inc.
The lenses are manufactured in senofilcon C material, which has a water content of 41% and a reported Dk/t of 129. Parameters include center thickness at –3.00D of 0.080mm; 8.6mm base curve, and 14.5mm diameter. The low-minus power range includes sphere powers of plano to –6.00D (0.25D steps) with cylinder powers of –0.75D, –1.25D, and –1.75D in axes of 10º to 180º (10º increments) and cylinder power of –2.25D in axes of 70º to 110º and 20º to 160º (10º increments). The high-minus power range includes sphere powers of –6.50D to –9.00D (0.50D steps) with cylinder powers of –0.75D, –1.25D, and –1.75D in axes of 70º to 110º and 20º to 160º (10º increments). The plus-power range includes sphere powers of +0.25D to +4.00D (0.25D steps) in cylinder powers of –0.75D, –1.25D, and –1.75D in axes of 70º to 110º and 20º to 160º (10º increments).
Ampleye Receives FDA Clearance for Therapeutic Management of OSD
Art Optical Contact Lens has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its Ampleye Scleral lens for the therapeutic management of ocular surface disease from dry eye.
The specific therapeutic indications for Ampleye include ocular pemphigoid, Stevens-Johnson syndrome, symblepharon formation, graft-versus-host disease, persistent epithelial defect, exposure keratitis, neurotrophic keratopathy (herpes simplex, herpes zoster, familial dysautonomia), Sjögren’s syndrome, filamentary keratitis, limbal stem cell deficiency, atopy, and ectodermal dysplasia. The indication covers Ampleye lenses manufactured in roflufocon D, roflufocon E, hexafocon A, and paflufocon D.
AAOF Selects Contact Lens Residency Award Recipient
Jesus Gabriel Martinez, OD, cornea and contact lens fellow at the University of Houston, was chosen by a committee of members in the Cornea, Contact Lenses and Refractive Technologies Section of the American Academy of Optometry (AAO) as this year’s recipient for the Bert C. & Lydia M. Corwin Residency Award.
The award is intended to promote the practice and development of the field of contact lenses by providing incentive and support to talented optometric residents who demonstrate a passion and commitment to practice, research, and education. Of the 16 applicants who applied to the program, Dr. Martinez presented an impressive resume of experience in clinical, volunteer service, research, and lecture presentation. He will receive a $2,000 education award and a $750 travel fellowship to attend Academy 2017 Chicago in October.
CooperVision Kicks Off Search for Third Class of Best Practices Honorees
CooperVision announced its third annual call for submissions for Best Practices. All U.S. optometry practices currently fitting contact lenses are eligible to apply.
Best Practices candidates are encouraged to submit practice profiles and stories, sharing their insights and experiences in the following areas: * Innovation will be evaluated on contributions to the betterment of eye health and education, leveraging technology in interesting ways to grow the practice, and advancing the eyecare profession among the public. * Industry Leadership will be rated on how a practice advances the profession and leads the industry regionally, nationally, and even globally. * Patient Experience will be judged on how a practice delivers excellent eyecare experiences and education to its patients and on unique aspects of patient care.
Candidates can submit their stories via written response or video at EyeCareBestPractices.com. Applications will be accepted through Oct. 31, 2017 and will be reviewed by a panel of judges including past Best Practices honorees, industry experts, and CooperVision leaders. The 2018 Best Practices will be announced in early 2018.
Best Practices honorees are broadly recognized throughout the profession by serving on professional panels, showcasing their expertise within the eyecare trade media, and representing the program at industry trade shows. They are also invited to attend educational meetings at CooperVision’s headquarters in Pleasanton, CA.
Brien Holden’s influence in eye care in India has been immortalized following the inauguration of the Brien Holden Institute for Optometry and Vision Sciences by L.V. Prasad Eye Institute (LVPEI). The newly named institution, which incorporates the Bausch and Lomb School of Optometry, specializes in education, research, patient care, and human resource capacity building in optometry.
LVPEI, an eye research, treatment, and teaching hospital in India, has been a long-time collaborator with Brien Holden Vision Institute, dating back to the 1980s. Professor Holden first met Dr. Nag Rao, the founder and chair of LVPEI, in the 1970s, and Professor Holden helped develop LVPEI’s clinical research capabilities after it was established in 1987. His contributions were later recognized in the naming of the Prof. Brien Holden Eye Research Centre at LVPEI.
Both organizations were participants in a series of Cooperative Research Centres between 1991 and 2015 and were instrumental in the founding of the International Centre for Eyecare Education (later becoming the Brien Holden Vision Institute) and co-founded the India Vision Institute.
i-Pen Tear Osmolarity System Registered in Japan
I-MED Pharma announced the successful registration of its i-Pen Tear Osmolarity System in Japan. The i-Pen is an in-vivo handheld tear osmolarity device for the diagnosis and monitoring of dry eye disease. The system is currently approved for use in Canada and holds CE Marking in the European Union (EU).
Measurements are taken by touching the device to the inside of the tear-soaked conjunctiva on the inside lower eyelid for two to four seconds. During that time, the i-Pen takes 192 readings and then displays the result on its LCD screen.
I-MED Pharma also announced that its second-generation device with an additional two biomarkers is entering the final phase of clinical testing. Initial applications for regulatory approval are planned for the second half of 2018.
2017 AAO and AAO Foundation Student Travel Fellowship and Resident Travel Fellowship Recipients Announced
The American Academy of Optometry is pleased to congratulate the recipients of the 2017 Student Travel Fellowship Awards and Resident Travel Fellowship Awards. These travel fellowships will allow students and residents to attend Academy 2017 Chicago, Oct. 11 to 14, 2017. To see a full list of the 2017 recipients click here.
Do you concurrently prescribe a saline solution with a hydrogen peroxide-based care system to your contact lens wearers?
Sergey Cusato Jr., OD, São Paulo, Brazil
This clinical case shows a cornea with radial keratotomy, retouch, and LASIK incisions that had many complications. After complete clinical evaluation, it was decided that the patient would adapt to scleral lenses that had a large diameter.
We thank Professor Cusato for this image and welcome photo submissions from our other readers! It is easy to submit a photo for consideration for publishing in Contact Lenses Today. Simply visit http://www.cltoday.com/upload/upload.aspx to upload your image. Please include a detailed explanation of the photo and your full name, degree or title, and city/state/country.
CARE SOLUTION CORNER
Andrew D. Pucker, OD, PhD
Surpassing the Disinfection Standard
Each day, we prescribe care systems (chemical disinfection solutions) to contact lens users, and we educate them about how to properly clean their contact lenses. This is a task that should include a reminder to follow the manufacturers’ cleaning protocols because this is how the products were designed to work best.1 Development of contact lens care systems is regulated at least in part by the U.S. Food & Drug Administration’s (FDA) Premarket Notification (510(k)) Guidance Document for Contact Lens Care Products.2 The development of a care system involves a number of steps, two of which include selecting/creating the components and ensuring that the new product has adequate disinfection activity.2 While we might assume that a well-designed care system always reduce the microbial load to a safe level, this may not actually be the case in every circumstance.
In testing disinfection efficacy, manufacturers are directed to follow a defined testing protocol that utilizes standardized, representative microorganisms (Pseudomonas aeruginosa, Staphylococcus aureus, Serratia marcescens, Candida albicans, and Fusarium solani) acquired from a defined vendor.2 Care systems are then subjected to these organisms to determine whether the care system is able to reduce the microbial load by a specified amount that is dependent upon the organism being tested and the procedure being performed.
While care systems need to meet these standards, the guidance document does not require disinfection efficacy testing against other microbes such as Acanthamoeba species or strains of microbes that are known to be resistant to disinfection.3,4 Likewise, care system development does not fully take into account human errors that could lead to excessive buildup of microbes or debris, which may render an otherwise well-developed care system ineffective. Overall, we need to make sure that our patients follow good care and compliance practices while using their care system to optimize their contact lens wearing experience.
1. Pucker AD, Nichols JJ. Impact of a rinse step on protein removal from silicone hydrogel contact lenses. Optom Vis Sci. 2009 Aug;86:943-947.
2. Food and Drug Administration (FDA). Guidance for Industry: Premarket Notification (510(k)) Guidance Document for Contact Lens Care Products. 1997 May 1. Available at https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM080218.pdf. Accessed on Sep. 6, 2017.
3. Kal A, Toker MI, Kaya S. The comparison of antimicrobial effectiveness of contact lens solutions. Int Ophthalmol. 2016 Oct 13. [Epub ahead of print]
4. Johnston SP, Sriram R, Qvarnstrom Y, et al. Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solutions. J Clin Microbiol. 2009 Jul;47:2040-2045.
MATERIALS & DESIGNS
David L. Kading, OD
I Want Your Smarts
How many times have you said: “I wish I had a contact lens for __________”? Well, you’re in luck…the contact lens manufacturers want that feedback. More than anything else, the contact lens industry wants to know the technologies that would benefit us and our patients.
We do not live in a closed system. Rather, it is open. I have had the opportunity to meet with every contact lens company and share my opinions about their lenses. And, I can assure you that your opinions are just as important and valued as mine are. There are several avenues that you might want to take when reaching out to your contact lens company.
First, you can speak to your local industry representative. These professionals are the people who are directly assigned as your conduit to the company. Speak to them about the pulse point that you are wanting and what you think that your patients need.
Next, consider setting up time with someone from a company at a large eyecare meeting. Most of the manufacturers exhibit at these meetings for two purposes: 1) to share what they have in development and to showcase what is new; and 2) to meet you and hear you out.
Let’s be honest, our eyecare professionals are vision scientists. Although there are many employed scientists who work to bring about the “next great thing,” you may be able to catapult our profession or trigger a new idea.
I also—selfishly—want your ideas. We are only where we are because one day, long ago, one of us said: “wouldn’t it be cool if….”
Epidemiology of Contact Lens-Induced Infiltrates: An Updated Review
Corneal infiltrative events (CIEs) are well established as a risk associated with soft contact lens wear. The incidence of symptomatic CIEs during extended soft lens wear ranges from 2.5% to 6%; when asymptomatic CIEs are included, the incidence can be as high as 20% to 25%. In daily soft lens wear, the annual incidence of symptomatic CIEs is about 3%.
There are various accepted methods of categorizing CIEs, and a scoring system based on clinical signs and symptoms is a good approach to grade severity. Lens-related risk factors include extended wear, silicone hydrogel material, the use of multipurpose solutions, bacterial bioburden, and reusable lenses. Recent studies report that daily disposable lenses reduce the risk of CIEs.
Steele KR, Szczotka-Flynn L. Epidemiology of contact lens-induced infiltrates: an updated review. Clin Exp Optom. 2017 Sep 4. [Epub ahead of print]